These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26672766)

  • 21. Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Wang Y; Hong Y; Li M; Long J; Zhao YP; Zhang JX; Li Q; You H; Tong WM; Jia JD; Huang J
    PLoS One; 2013; 8(12):e82426. PubMed ID: 24349281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
    Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
    Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
    Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
    Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.
    Choi JH; Kim MJ; Park YK; Im JY; Kwon SM; Kim HC; Woo HG; Wang HJ
    Oncotarget; 2017 Apr; 8(14):22903-22916. PubMed ID: 28038442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
    Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
    Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.
    Vilarinho S; Erson-Omay EZ; Mitchell-Richards K; Cha C; Nelson-Williams C; Harmancı AS; Yasuno K; Günel M; Taddei TH
    J Hepatol; 2017 Jul; 67(1):186-191. PubMed ID: 28323122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
    Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M
    Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.
    Li L; Qian M; Chen IH; Finkelstein D; Onar-Thomas A; Johnson M; Calabrese C; Bahrami A; López-Terrada DH; Yang JJ; Tao WA; Zhu L
    Am J Pathol; 2018 Mar; 188(3):656-671. PubMed ID: 29248454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations.
    Chianchiano P; Pezhouh MK; Kim A; Luchini C; Cameron A; Weiss MJ; He J; Voltaggio L; Oshima K; Anders RA; Wood LD
    Hum Pathol; 2018 Feb; 72():127-134. PubMed ID: 29180252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.
    Lv J; Zhu P; Zhang X; Zhang L; Chen X; Lu F; Yu Z; Liu S
    Mol Med Rep; 2017 Oct; 16(4):4475-4482. PubMed ID: 28791409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.
    Miao R; Luo H; Zhou H; Li G; Bu D; Yang X; Zhao X; Zhang H; Liu S; Zhong Y; Zou Z; Zhao Y; Yu K; He L; Sang X; Zhong S; Huang J; Wu Y; Miksad RA; Robson SC; Jiang C; Zhao Y; Zhao H
    J Hepatol; 2014 Oct; 61(4):840-9. PubMed ID: 24859455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles.
    Yamaguchi H; Kuroda K; Sugitani M; Takayama T; Hasegawa K; Esumi M
    Int J Oncol; 2017 May; 50(5):1749-1759. PubMed ID: 28339069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma.
    Wang A; Wu L; Lin J; Han L; Bian J; Wu Y; Robson SC; Xue L; Ge Y; Sang X; Wang W; Zhao H
    Nat Commun; 2018 Mar; 9(1):894. PubMed ID: 29497050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Zhang N; Zhao Z; Long J; Li H; Zhang B; Chen G; Li X; Lv T; Zhang W; Ou X; Xu A; Huang J
    Oncol Rep; 2017 Dec; 38(6):3650-3658. PubMed ID: 29130106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
    Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
    J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.
    Mima K; Hayashi H; Imai K; Kuroki H; Nakagawa S; Okabe H; Chikamoto A; Watanabe M; Beppu T; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Apr; 20(4):429-34. PubMed ID: 23238743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.